Home Search
hapbee - search results
If you're not happy with the results, please do another search
Interview: Scott Donnell from Hapbee (HAPB, HAPBF) on Wall Street Reporter.
Transcript follows.
Hapbee CEO Live with the Wall Street Reporter
Listen in as Hapbee CEO...
Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head...
Things that make you go mmmm.
Randy Eisenman is co-founder and managing partner of Satori Capital with more than...
Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.
Hapbee Announces Additions to Advisory Board
December 17, 2020
New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
Hapbee (HAPB): The Netflix of Feelings
After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.
My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
Adding Hapbee (HAPB) to the Watch List.
Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...
Hapbee’s (HAPB) Device, “Choose How You Feel.”
HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL'
Proprietary, Research-Backed...
Hapbee (HAPB) Provides Update. Over 1,800 Devices Delivered.
Hapbee Provides Update on Recent Corporate Developments - Manufactured and Shipped Over 1,800 Hapbee Wearables to Early Adopters, Fulfilled All Orders from...
Hapbee Technologies (HAPB): Updates and News Archive.
Recent Headlines
UPDATED CONTINUOUSLY.
June 4, 2021: Hapbee (HAPBF) Selects Accomplished...
Hapbee (HAPB) Soars 136% the First Day of Trading!
LIVE QUOTE
Subscribe here for upcoming report.
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
